Semmax Financial Advisors’s GSK GSK Stock Holding History

Semmax Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$4.03M	Buy	106,534 +2,131	+2%	+$81.4K	1.04%	40
2025 Q1	$3.82M	Buy	104,403 +5,686	+6%	+$208K	1.03%	40
2024 Q4	$3.61M	Buy	98,717 +8,549	+9%	+$308K	0.96%	42
2024 Q3	$3.2M	Buy	90,168 +2,083	+2%	+$85.2K	0.88%	49
2024 Q2	$3.63M	Buy	88,085 +502	+0.6%	+$21.1K	1.09%	35
2024 Q1	$3.96M	Sell	87,583 -7,296	-8%	-$301K	1.3%	26
2023 Q4	$3.93M	Sell	94,879 -4,605	-5%	-$165K	1.43%	23
2023 Q3	$3.44M	Buy	+99,484	New	+$3.53M	1.38%	29
2022 Q4	$6K	Buy	+160	New	+$5.33K	﹤0.01%	191
2020 Q4	–	Sell	-78	Closed	-$4K	–	256
2020 Q3	$4K	Hold	78	–	–	﹤0.01%	181
2020 Q2	$4K	Hold	78	–	–	﹤0.01%	197
2020 Q1	$4K	Sell	78 -101	-56%	-$5.39K	﹤0.01%	193
2019 Q4	$11K	Sell	179 -22	-11%	-$1.22K	0.01%	168
2019 Q3	$11K	Buy	201 +22	+12%	+$1.13K	0.01%	168
2019 Q2	$9K	Sell	179 -9,855	-98%	-$495K	0.01%	191
2019 Q1	$524K	Sell	10,034 -11,193	-53%	-$559K	0.36%	78
2018 Q4	$1.01M	Buy	+21,227	New	+$1.05M	0.79%	29

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Semmax Financial Advisors's GSK Position: Q2 2025 in Review

Semmax Financial Advisors increased its GSK (GSK) stake by 2% in Q2 2025, buying an estimated $81.4K and bringing the position to 106,534 shares worth $4.03M. The position accounts for 1.04% of the portfolio, ranked #40.

Semmax Financial Advisors first reported a position in GSK in Q4 2018 and has held it in 17 quarters since. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Semmax Financial Advisors held 106,534 shares of GSK worth $4.03M as of Q2 2025.
Semmax Financial Advisors bought 2,131 GSK shares in Q2 2025, an estimated $81.4K.
GSK made up 1.04% of Semmax Financial Advisors's portfolio in Q2 2025, its #40 holding.
Semmax Financial Advisors first reported a position in GSK in Q4 2018 and has held it in 17 quarters since.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.